CHROMagar, a chromogenic differential culture medium, is claimed to facilitate the isolation and presumptive identification of certain clinically important yeast species, e.g., Candida albicans. This study evaluated the cost-effectiveness and time advantage of using it in comparison with Sabouraud dextrose agar (SDA). Three possible pathways, each of which included the use of one or both media, were compared in a routine laboratory. A total of 21 yeast isolates was cultured from 298 clinical samples from neutropenic and AIDS patients. An overall sensitivity of 95.2% was observed for each medium and primary isolation on CHROMagar was found to be 100% sensitive and 100% specific for C. albicans. For identification purposes, after initial culture the use of CHROMagar provided the most economical and least time-consuming method. Direct inoculation on to CHROMagar is recommended for blood cultures when yeast cells are seen on microscopy and where early appropriate therapy is imperative.
OddsF. C.,
BemaertsR. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol1994; 32:1923–1929
LouwagieB.,
SurmontI.,
VerhaegenJ.,
OddsF. Differential and enrichment media for selective culture and recognition of yeast species from clinical material. Eur J Clin Microbiol Infect Dis1995; 14:406–411
PfallerM. A.,
HoustonA.,
CoffmannS. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei and Candida glabrata (Torulopsis). J Clin Microbiol1996; 34:58–61
WelcanU. K. Workload measurement system manual; 1992 edn
BaumgartnerC.,
FreydiereA.-M.,
GilleY. Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates. J Clin Microbiol1996; 34:454–456
BemalS.,
Martin MazuedosE.,
GarciaM.,
AllerA. I.,
MartinezM. A.,
GutierrezM. J. Evaluation of CHROMagar Candida medium for the isolation and presumptive identification of species of Candida of clinical importance. Diagn Microbiol Infect Dis1996; 24:201–204
San-MillanR.,
RibacobaL.,
PontonJ.,
QuindosG. Evaluation of a commercial medium for identification of Candida species. Eur J Clin Microbiol Infect Dis1996; 15:153–158
Working Parties of the British Society for Antimicrobial Chemotherapy and the British Society for Medical Mycology 1996 Fungal infections: a survey of laboratory services for diagnosis and treatment. Commun Dis Rep CDR Review1996; 6:5